OBSERVATIONAL STUDY CASE-CONTROL (EPIDEMIOLOGY)
|
2017
Haider A
Haider KS
Saad F
Endocrinol Diabetes Metab Case Rep. 2017 Sep 4;2017
Summary
In daily practice, clinicians are often confronted with obese type 2 diabetes mellitus (T2DM) patients for whom the treatment plan fails and who show an inadequate glycemic control and/or no sustainable weight loss. Untreated hypogonadism can be the reason for such treatment failure.
This case describes the profound impact testosterone therapy can have on a male hypogonadal patient with metabolic syndrome, resulting in a substantial and sustained loss of body weight, pronounced improvement of all critical laboratory values and finally complete remission of diabetes.
Keywords
dyslipidemia
hypertension
coronary artery disease
CAD
classical cardiovascular disease
risk factors
blood pressure
lipids
glycemic control
obesity
testosterone undecanoate
nebido
Comments
Testosterone Preparation
testosterone undecanoate